Η παρούσα ανάρτηση απευθύνεται μόνο σε επαγγελματίες υγείας.
Διαβήτης και Τεχνολογία – Ενημέρωση 2024 – Ειδική Έκδοση από την Diabetologia -Journal of the EASD
https://doi.org/10.1007/s00125-024-06235-z
Απόσπασμα:
Diabetes technology also provides new routes for insulin administration. Insulin was originally delivered using reusable glass syringes with large needles, but these were replaced with inulin pens. In the 1960s, we saw the frst insulin pump, which provided continuous insulin infusion; however, this was referred to as ‘an army backpack’ and was impractical [3]. This development was followed by continuous subcutaneous insulin infusion (CSII) and, since then, the evolution of insulin pumps has been remarkable (see Fig. 1).
Advances in technology have also had an impact on other aspects of diabetes care, such as education using digital applications (apps), telehealth and telemedicine, and data integration to facilitate communication with healthcare professionals (see text box for further details). In addition, technology has been useful for peer support and education for individuals with diabetes (e.g. social media, Diabetes 101 [4], REVOLVE comics [5] and D-coded [6]) and for medical education and evaluation for healthcare professionals
involved in the delivery of technology for people with type 1 diabetes (e.g. the UK’s Diabetes Technology Network [DTN-UK] [7]).
With the recent and ongoing advances in diabetes technology, we believe it is timely to create a special issue on this important subject. Hence, in this issue, we include nine comprehensive reviews spanning an array of topics, from the use of diabetes technology in diferent diabetes populations (e.g. type 2 diabetes, older adults, children and pregnant individuals) to the application of these devices in individuals with diabetes and comorbidities, such as cystic fbrosis-related diabetes (CFRD) and chronic kidney disease. In addition, we present reviews on the use of diabetes technology in unique contexts, such as in hospitalised individuals or during exercise.
Most importantly, we have strived to ensure that the voices of individuals living with diabetes are at the forefront of the discussion. To do this, we have been fortunate enough to work with a group of ten inspiring individuals living with diabetes from around the globe who have generously shared their direct Diabetologia 2 experiences of diabetes technology with us, and we are eager to share their views with you. In this editorial, we will summarise the content of this special issue, but ultimately hope that we encourage you to delve deeper into this exciting and groundbreaking topic.
Download (πλήρης δημοσίευση) »»
Υπεργλυκαιμικές κρίσεις – Ενημέρωση 2024
Hyperglycaemic crises in adults with diabetes: a consensus report
Diabetologia (2024) 67:1455–1479 https://doi.org/10.1007/s00125-024-06183-8
The American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD), Joint British Diabetes Societies for Inpatient Care (JBDS), American Association of Clinical Endocrinology (AACE) and Diabetes Technology Society (DTS) convened a panel of internists and diabetologists to update the ADA consensus statement on hyperglycaemic crises in adults with diabetes, published in 2001 and last updated in 2009. The objective of this consensus report is to provide up-to-date knowledge about the epidemiology, pathophysiology, clinical presentation, and recommendations for the diagnosis, treatment and prevention of diabetic ketoacidosis (DKA) and hyperglycaemic hyperosmolar state (HHS) in adults. A systematic examination of publications since 2009 informed new recommendations. The target audience is the full spectrum of diabetes healthcare professionals and individuals with diabetes.
Download (πλήρης δημοσίευση) »»